NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company dedicated to developing therapies for rare and complex central nervous ...

Reversing opioid overdoses in rats using a drug that does not enter the brain prevents the sudden and severe withdrawal symptoms associated with therapeutics that target the central nervous system.

A new study from researchers at UC San Francisco has found that a treatment approach designed to help people addicted to fentanyl, using low doses of buprenorphine, is not working as expected. The ...

Proponents of the plan to equip paramedics with buprenorphine call it the "missing link" in the bridge to recovery for many ...

A new study conducted by University of California San Francisco researchers found buprenorphine works for treating opioid use ...

Medical experts believe nalmefene shouldn’t replace naloxone because of an increased risk for severe withdrawal symptoms ...

You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...

A new "powerful tool" for combatting opioid deaths isn't settled science. For that reason, the state is taking a measured ...

Overdose deaths in Whatcom County soared from 91 in 2022 to 137 in 2023, fueled by cheap and easily available drugs — ...

The program's expansion is being funded by money Orange County received through national legal settlements with opioid ...